ORCL insider files Form 4 detailing sales near $282–$284
Rhea-AI Filing Summary
Oracle (ORCL) director reported insider sales. On 10/28/2025, The Berg Family Trust executed multiple sales of Oracle common stock: 9,042, 13,373, 22,724, and 4,226 shares at weighted-average prices of $281.579, $282.555, $283.627, and $284.307, respectively.
Following these transactions, 151,999 shares were beneficially owned indirectly by The Berg Family Trust, and 5,000 shares were held indirectly by the spouse.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 9,042 | $281.579 | $2.55M |
| Sale | Common Stock | 13,373 | $282.555 | $3.78M |
| Sale | Common Stock | 22,724 | $283.627 | $6.45M |
| Sale | Common Stock | 4,226 | $284.307 | $1.20M |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- This transaction was executed in multiple trades at prices ranging from $281.06 to $282.00. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $282.05 to $283.03. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $283.08 to $284.075. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $284.085 to $284.04. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
FAQ
What insider transaction did ORCL disclose?
What was the insider’s relationship to Oracle (ORCL)?
Were the ORCL sales executed in multiple trades?
Was a Rule 10b5-1 plan indicated?